US 8,012,096 B2Granted

Surgical device and method for performing combination revascularization and therapeutic substance delivery to tissue

AssigneeCardiogenesis Corporation

InventorsJohn McIntyre, Elbert Tzeng

Life of this patent

Estimating the term…

Loading patent…

Abstract

The present invention contemplates a surgical device for both ablating a channel in a patient's tissue and also delivering a therapeutic agent. The device includes an elongated multi-lumen tube, an elongated tissue ablating assembly, and a therapeutic agent delivery assembly. The therapeutic agent is capable of being delivered into the channel and/or to the surrounding tissue. The device may further include a second multi-lumen tube also capable of delivering therapeutic agents. Although suitable for many operations, the device is particularly well suited for transmyocardial revascularization operations. The present invention also contemplates a procedure for using such a surgical device to ablate a channel in a patient's tissue and also deliver a therapeutic agent.

Claims26

Dependent claims

A surgical device for ablating a channel and delivering at least one therapeutic agent into a desired region of tissue, comprising:

(a) a first elongated multi-lumen tube;
(b) an elongated tissue ablating assembly supported in a first lumen of the first multi-lumen tube, said ablating assembly extending from a source of laser energy into an ablating tip adapted for ablating a channel into the tissue;
(c) a therapeutic agent delivery assembly supported in a second lumen of the multi-lumen tube, said therapeutic agent delivery assembly having a proximal end adapted for receiving a source of the therapeutic agent and extending distally through the second lumen to a delivery tip, the delivery assembly adapted for receiving the therapeutic agent and providing a conduit to the delivery tip wherein the ablating tip and therapeutic agent delivery tip are located sufficiently close such that the therapeutic agent can be delivered into a channel formed by the ablating tip;
and
(d) a second elongated multi-lumen tube having at least a first lumen and a second lumen, the first lumen supporting the first multi-lumen tube and the second lumen having a proximal end adapted for receiving a second therapeutic agent and extending through the second multi-lumen tube into a second delivery tip, said second lumen adapted for receiving the second therapeutic agent and providing a conduit to the second delivery tip;
(e) at least one actuator operatively coupled to said first elongated multi-lumen tube and said second elongated multi-lumen tube, said at least one actuator being operatively transitional between a first retracted configuration, a second intermediate configuration and a third extended configuration, said first elongated multi-lumen tube correspondingly extending distally from said second elongated multi-lumen tube as said at least one first actuator transitions from said first retracted configuration to said second intermediate configuration, and said first elongated multi-lumen tube and said second elongated multi-lumen tube operatively extending equidistantly and along a common axis relative one another as said at least one first actuator transitions from said second intermediate configuration to said third extended configuration;
wherein the first therapeutic agent and the second therapeutic agent are dispersed into the tissue simultaneously, in various sequences or according to a timing schedule;
f) an outer guide tube adapted for supporting at least a portion of the first and second multi-lumen tubes;
and
g) a handle assembly for controlling the translation of the second dispensing tip relative to the ablating tip.

7 more elements

A device for performing a combination revascularization and therapeutic agent treatment to a region of tissue, comprising:

(a) an ablating means for receiving laser energy and delivering it to an ablating tip, the ablating means having a proximal end adapted for connection with a source of the laser energy and extending to the ablating tip for creating a channel in the tissue;
(b) a first therapeutic agent delivery assembly having a proximal end adapted for connection to a first source of therapeutic agent and extending distally to a delivery tip, said delivery tip disposed proximally to the ablating tip such that the therapeutic agent may be dispensed directly into the channel;
(c) a second therapeutic agent delivery assembly having a proximal end adapted for connection to a second source of therapeutic agent and extending distally to an injection tip for injecting the therapeutic agent directly into tissue adjacent the channel;
and
(d) a guide tube supporting the ablating means, the first therapeutic agent delivery assembly and the second therapeutic agent delivery assembly;
(e) a first actuator operatively coupled to said ablating means and said first therapeutic agent delivery assembly and operative to linearly extend said delivery tip and said ablating tip into said region of tissue and selectively retract said delivery tip and ablating tip therefrom;
(f) a second actuator operatively coupled to said second therapeutic agent delivery assembly and operative to selectively extend and retract said injection tip from said region of tissue,
wherein the first therapeutic agent delivery assembly and the second therapeutic agent delivery assembly are capable of delivering at least a first therapeutic agent and a second therapeutic agent into the region of tissue simultaneously, in various sequences or according to a timing schedule, said first actuator and said second actuator operating independently of one another;
and
g) a handle assembly in connection with the second therapeutic aunt delivery assembly and the guide tube, the handle having a control mechanism for controlling the extension of the injection tip relative to the guide tube.

7 more elements

A transmyocardial revascularization and therapeutic agent delivery system comprising:

a) a first elongated multi-lumen tube;
b) a first therapeutic agent delivery assembly having a proximal end adapted for connection with a source of a first therapeutic agent and extending through a lumen of the first multi-lumen tube to a first therapeutic agent delivery tip;
c) a second elongated multi lumen tube extending through a second lumen of the first multi lumen tube;
d) a revascularization treatment assembly having a proximal end adapted for connection with an ablating energy and extending through a first lumen of the second multi-lumen tube to an ablating tip;
e) a second therapeutic agent delivery assembly having a proximal end adapted for connection with a source of therapeutic agent and extending through a second lumen of the second multi-lumen lumen tube to a second therapeutic agent delivery tip;
and
f) a control mechanism in connection with the first multi-lumen tube and the second multi-lumen tube and adapted such that actuation of the control assembly extends the ablating tip and second therapeutic agent delivery tip relative the first therapeutic agent delivery tip and thereafter operatively extends the ablating tip, second therapeutic agent delivery tip and said first therapeutic agent delivery tip distally about a common axis;
wherein the first therapeutic agent delivery assembly and the second therapeutic agent delivery assembly are capable of delivering at least a first and a second therapeutic agent into the region of tissue simultaneously, in various sequences or according to a timing schedule;
g) a handle assembly supporting the control mechanism;
h) a guide tube extending from the handle assembly to a distal end, said first multi-lumen tube extending through and slideably supported within said guide tube;
and
i) a laser in connection with a fiber optic that extends through the second multi-lumen lumen tube to the ablating tip.

9 more elements

Dependencies are inferred from the claim text.

Facts

Application: 11/543,505Filed 5 Oct 2006 · us provisional application
Priority: 17 Oct 2005
Published: US 2007/0088218 A119 Apr 2007
Granted: 6 Sep 2011
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61B 17/3478
Trocars; Puncturing needles: endoscopic needles, e.g. for infusion
A61B 18/24
The beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor: with a catheter
A61B 18/1477
Probes or electrodes therefor: needle-like probes
A61B 2017/00243
Type of minimally invasive operation: cardiac